Is Bendroflumetiazida Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use Bendroflumetiazida? Is Bendroflumetiazida safe for nursing mother and child? Does Bendroflumetiazida extracts into breast milk? Does Bendroflumetiazida has any long term or short term side effects on infants? Can Bendroflumetiazida influence milk supply or can Bendroflumetiazida decrease milk supply in lactating mothers?

• DrLact safety Score for Bendroflumetiazida is 5 out of 8 which is considered Unsafe as per our analyses.
• A safety Score of 5 indicates that usage of Bendroflumetiazida may cause serious side effects in breastfed baby.
• Our study of different scientific research indicates that Bendroflumetiazida may cause moderate to high side effects or may affect milk supply in lactating mother.
• Our suggestion is to use safer alternate options rather than using Bendroflumetiazida .
• It is recommended to evaluate the advantage of not breastfeeding while using Bendroflumetiazida Vs not using Bendroflumetiazida And continue breastfeeding.
• While using Bendroflumetiazida Its must to monitor child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
• Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Thiazide diuretic. Long-term treatment with diuretic drugs (particularly those Thiazides with long lasting effect and loop-acting drugs) may inhibit lactation. Use a lower dose as possible especially during the first postnatal month. Diretic used to supress lactation.

If Bendroflumetiazida is required by the mother, it is not a reason to discontinue breastfeeding. Intense diuresis with large doses of Bendroflumetiazida can decrease breastmilk production, especially during the neonatal period. Shorter-acting diuretics in low doses are preferred over Bendroflumetiazida.

Bendroflumetiazida has been used to suppress lactation in oral doses of 5 mg twice daily for 5 days,[1] and in doses of 10 mg in the morning and 5 mg in the afternoon.[2] The added contribution of the diuretic to these measures, which are effective in suppressing lactation, has not been studied. There are no data on the effects of potent diuretics on established, ongoing lactation.